thymoquinone has been researched along with Candidiasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ayatollahi Mousavi, SA; Jahantiq, AS; Mohamadi, N; Sharififar, F | 1 |
| Aldebasi, YH; AlSahli, MA; Alsuhaibani, SA; Alzohairy, MA; Khan, A; Khan, MA; Younus, H | 1 |
| Aljarbou, AN; Khan, A; Khan, MA; Younus, H | 1 |
3 other study(ies) available for thymoquinone and Candidiasis
| Article | Year |
|---|---|
Inhibitory Effect of Standardized Extract and Fractions of
Topics: Antifungal Agents; Benzoquinones; Candida albicans; Candidiasis; Humans; Microbial Sensitivity Tests; Nigella sativa; Nystatin; Plant Extracts | 2022 |
Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice.
Topics: Animals; Benzoquinones; Blood Glucose; Candida albicans; Candidiasis; Diabetes Mellitus, Experimental; Disease Models, Animal; Humans; Liposomes; Liver; Mice | 2018 |
Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model.
Topics: Animals; Antifungal Agents; Benzoquinones; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Female; Fluconazole; Liposomes; Macrophages; Mice; Microbial Sensitivity Tests | 2015 |